SLABÁKOVÁ, Eva, G. KHARAISHVILI, Monika SMĚJOVÁ, Zuzana PERNICOVÁ, Tereza SUCHÁNKOVÁ, Ján REMŠÍK, Stanislav LERCH, Nicol STRAKOVÁ, Jan BOUCHAL, Milan KRÁL, Z. CULIG, Alois KOZUBÍK and Karel SOUČEK. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells. Oncotarget. Albany: Impact Journals, 2015, vol. 6, No 34, p. 36156-36171. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.5392.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells
Authors SLABÁKOVÁ, Eva (203 Czech Republic, belonging to the institution), G. KHARAISHVILI (268 Georgia), Monika SMĚJOVÁ (203 Czech Republic, belonging to the institution), Zuzana PERNICOVÁ (203 Czech Republic), Tereza SUCHÁNKOVÁ (203 Czech Republic), Ján REMŠÍK (703 Slovakia, belonging to the institution), Stanislav LERCH (203 Czech Republic, belonging to the institution), Nicol STRAKOVÁ (203 Czech Republic, belonging to the institution), Jan BOUCHAL (203 Czech Republic), Milan KRÁL (203 Czech Republic), Z. CULIG (40 Austria), Alois KOZUBÍK (203 Czech Republic, belonging to the institution) and Karel SOUČEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Oncotarget, Albany, Impact Journals, 2015, 1949-2553.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.008
RIV identification code RIV/00216224:14310/15:00100428
Organization unit Faculty of Science
Doi http://dx.doi.org/10.18632/oncotarget.5392
UT WoS 000366111900087
Keywords in English epithelial-mesenchymal transition; MDM2/MDMX; SNAI2/SLUG; TWIST; prostate/breast cancer
Tags NZ, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Nicole Zrilić, učo 240776. Changed: 13/4/2018 16:03.
Abstract
Plasticity of cancer cells, manifested by transitions between epithelial and mesenchymal phenotypes, represents a challenging issue in the treatment of neoplasias. Both epithelial-mesenchymal transition (EMT) and mesenchymalepithelial transition (MET) are implicated in the processes of metastasis formation and acquisition of stem cell-like properties. Mouse double minute (MDM) 2 and MDMX are important players in cancer progression, as they act as regulators of p53, but their function in EMT and metastasis may be contradictory. Here, we show that the EMT phenotype in multiple cellular models and in clinical prostate and breast cancer samples is associated with a decrease in MDM2 and increase in MDMX expression. Modulation of EMT-accompanying changes in MDM2 expression in benign and transformed prostate epithelial cells influences their migration capacity and sensitivity to docetaxel. Analysis of putative mechanisms of MDM2 expression control demonstrates that in the context of defective p53 function, MDM2 expression is regulated by EMT-inducing transcription factors Slug and Twist. These results provide an alternative context-specific role of MDM2 in EMT, cell migration, metastasis, and therapy resistance.
PrintDisplayed: 28/7/2024 10:23